
Alzheimer’s Drug Leqembi Gets Full FDA and MEDICARE Approval
First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.

First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.

More magnesium in our daily diet leads to better brain health as we age, according to scientists from the Neuroimaging and Brain Lab at The Australian National University (ANU).

A large study led by Lund University in Sweden has shown that people with Alzheimer’s disease can now be identified before they experience any symptoms.

The FDA Advisory Committee’s endorsement of Leqembi paves way for traditional approval, ushers in a new era for Alzheimer’s

Taking a daily multivitamin supplement can slow age-related memory decline, researchers found.

More proof that you are what you eat, at least to a certain extent. Researchers found those who follow the MIND or Mediterranean diet showed fewer signs of Alzheimer’s in their brains. Learn more.

New research suggests choline—a nutrient linked to memory and cognitive resilience—may help people with Alzheimer’s and at high dementia risk. Here’s why nuts, a heart-healthy and cholesterol-free food, can play a powerful role in daily dementia care.

In dementia, people repeatedly ask, “What’s the time?” “What day is it?” Easily solve this with Dementia-clocks / Calendar-clocks. Check out 7 clocks with good looks and limitless patience.

VIDEO & ARTICLE – CARE TIPS:
This season is filled with family and friends, laughter and reminiscing. Learn ways to prevent dementia’s stress, frustration, and loneliness. Fill the holiday with joy.

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


